Chairman of the Board of Directors
James M. Rae is Chairman of the Board of Directors of Receptor Therapeutics Inc. He is also President and Chief Executive Officer of Viron Inc. of London, Ontatio. James Rae brings over 30 years of experience in the manufacturing, marketing, financial, human resource and R & D operations of pharmaceutical and biotechnology firms. He has considerable experience in fund-raising/financing from public, private and government sectors, and in deal-making with multi-national companies. James Rae is the President and founder of Remedis, a health-care business consultancy specializing in the re-structuring and financing of health-care businesses. Prior to establishing Remedis, he was President and C.E.O. of Cangene, a publicly-listed biotech company where he was responsible for re-structuring and orchestrating a reverse take-over of the company. Mr. Rae was previously the Chairman and C.E.O. of Vaxis Therapeutics Inc. in Kingston, Ont., and Chairman and C.E.O. of Resolution Pharmaceuticals. Most recently he has been the C.E.O. of Cytochroma Inc., a Markham-based biotech company which he transitioned over an 18-month period from a research entity into one advanced into clinical development with a diversified product base. Mr. Rae is presently Chairman of Queens Scientific Breakthrough Fund (Kingston) and holds directorships in a number of Canadian biotech companies.